Daclizumab Subcutaneous and Dolotranz
Determining the interaction of Daclizumab Subcutaneous and Dolotranz and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: lidocaine / prilocaine topical
Brand name: Emla, Emla Anesthetic Disc, Livixil Pak, AgonEaze, Prizopak, LiproZonePak, Medolor Pak, Anodyne LPT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Dolutegravir
- Daclizumab Subcutaneous-Dolutegravir 10 mg
- Daclizumab Subcutaneous-Dolutegravir 25 mg and 50 mg
- Daclizumab Subcutaneous-Dolutegravir and lamivudine
- Daclizumab Subcutaneous-Dolutegravir and rilpivirine
- Daclizumab Subcutaneous-Dolutegravir Sodium
- Dolotranz-Dacogen
- Dolotranz-Dacomitinib
- Dolotranz-Dactinomycin
- Dolotranz-Dactinomycin Injection
- Dolotranz-Dactinomycin Intravenous
- Dolotranz-Daklinza